Michael A. Desjardin

SVP, Product Development, Jazz Pharmaceuticals.

Companies

Horizon Therapeutics Public Ltd CoEVP, Technical Operations Mar 3, 2017 to Oct 6, 2023¹
Jazz PharmaceuticalsSVP, Product Development Feb 16, 2011 to Aug 15, 2011²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Oct 6, 2023Returned to company 126,838 shares at $116.50 of Horizon Therapeutics Public Ltd Co³
Mar 2, 2023Exercised options 743 shares at $17.19 of Horizon Therapeutics Public Ltd Co⁴
Mar 2, 2023Exercised options 3,629 shares at $14.93 of Horizon Therapeutics Public Ltd Co⁴
Jan 5, 2023Shares withheld for tax 26,901 shares at $113.24 of Horizon Therapeutics Public Ltd Co⁵
Jan 5, 2023Exercised options 54,253 shares of Horizon Therapeutics Public Ltd Co⁵
Jan 1, 2023Shares withheld for tax 9,561 shares at $113.80 of Horizon Therapeutics Public Ltd Co⁶
Jan 1, 2023Exercised options 21,772 shares of Horizon Therapeutics Public Ltd Co⁶
Jun 1, 2022Granted 277 shares of Horizon Therapeutics Public Ltd Co⁷
Apr 12, 2022Sold 11,064 shares at $113.60 of Horizon Therapeutics Public Ltd Co⁸
Apr 12, 2022Sold 9,150 shares at $112.55 of Horizon Therapeutics Public Ltd Co⁸
Mar 2, 2022Sold 13,518 shares at $97.42 of Horizon Therapeutics Public Ltd Co⁹
Mar 2, 2022Sold 21,482 shares at $97.05 of Horizon Therapeutics Public Ltd Co⁹
Jan 21, 2022Shares withheld for tax 1,825 shares at $86.42 of Horizon Therapeutics Public Ltd Co¹⁰
Jan 21, 2022Exercised options 3,679 shares of Horizon Therapeutics Public Ltd Co¹⁰
Jan 5, 2022Shares withheld for tax 41,276 shares at $101.84 of Horizon Therapeutics Public Ltd Co¹¹
Jan 5, 2022Granted 32,301 shares of Horizon Therapeutics Public Ltd Co¹¹
Jan 5, 2022Exercised options 53,734 shares of Horizon Therapeutics Public Ltd Co¹¹

The numbers on this page point here. Each one links to the record it came from.